GSK Drug From $2B Deal Sputters in Phase 3 Test in Chronic Cough
GSK mentioned the blended Section 3 outcomes for camlipixant imply this capsule “is unlikely to remodel affected person care” in ...
Tag: GSK
GSK Gets a Pair of Near-Commercial Lung Cancer Drugs via $10.6B Nuvalent Acquisition
GSK’s oncology technique had targeted on gynecological and blood cancers, however the pharmaceutical firm is putting offers that broaden its ...
GSK to buy 35Pharma, picking up lung disease drug
Andrew Joseph covers well being, medication, and the biopharma business in Europe. You'll be able to attain Andrew on Sign ...
We’re reading about GSK drug comeback, a pricey Vertex medicine
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you ...
Amgen, Pfizer, abortion pill, GSK: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
BioNTech to Pay CureVac, GSK $740M Plus Royalties to Settle mRNA Patent Disputes
When BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some ...
GSK pays $500M for rights to drugs from Chinese firm Hengrui
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45.LONDON — ...
Spero, GSK, Eli Lilly, Rocket, Novavax
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Novo, GSK, CRISPR, Prime, COPD
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Eli Lilly, Novo Nordisk, FDA, Makary, GSK
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!